Study details
Enrolling now
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
University of Nebraska
NCT IDNCT05070013ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 4.6 years
Ages
18–80
Locations
2 sites in NE, PA
What this study is about
This trial is testing whether adaptive stimulation of the Subthalamic Nucleus (STN) can improve sleep quality and maintenance in people with Parkinson's disease. Participants will receive deep brain stimulation treatments, alternating between stimulation and no stimulation, to see if it affects their sleep patterns.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Deep Brain Stimulation
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Subjective Sleep Quality
Devices
implantable
Body systems
Neurology